↓ Skip to main content

我が国で使用可能な抗インフルエンザ薬とその薬理学的特性

Overview of attention for article published in Farumashia, December 2019
Altmetric Badge

About this Attention Score

  • Above-average Attention Score compared to outputs of the same age (52nd percentile)
  • Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

patent
2 patents
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
我が国で使用可能な抗インフルエンザ薬とその薬理学的特性
Published in
Farumashia, December 2019
DOI 10.14894/faruawpsj.55.12_1116
Authors

砂川 智子, 藤田 次郎, 中村 克徳

Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 3. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 July 2022.
All research outputs
#8,731,930
of 25,852,155 outputs
Outputs from Farumashia
#70
of 460 outputs
Outputs of similar age
#179,439
of 481,237 outputs
Outputs of similar age from Farumashia
#2
of 8 outputs
Altmetric has tracked 25,852,155 research outputs across all sources so far. This one is in the 43rd percentile – i.e., 43% of other outputs scored the same or lower than it.
So far Altmetric has tracked 460 research outputs from this source. They receive a mean Attention Score of 3.3. This one has gotten more attention than average, scoring higher than 60% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 481,237 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 52% of its contemporaries.
We're also able to compare this research output to 8 others from the same source and published within six weeks on either side of this one. This one has scored higher than 6 of them.